GOBLET: a phase I/II study of pelareorep and atezolizumab +/- chemo in advanced or metastatic gastrointestinal cancers
Year: 2022
Type: article
Source: Future Oncology
Institutions: Asklepios Klinik Altona, Asklepios, Oncolytics Biotech (Canada)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Oncolytics Biotech
OpenAlex ID: W4284691541